Specify a stock or a cryptocurrency in the search bar to get a summary
NIGHTINGALE HEALTH EO 1
7XENightingale Health Oyj, a health technology company, offers health data platform that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Health Check Remote where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. The company has research collaboration agreement with ZOE Limited for its blood collection device. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland. Address: Mannerheimintie 164a, Helsinki, Finland, 00300
Analytics
WallStreet Target Price
1.9 EURP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 7XE
Dividend Analytics 7XE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 7XE
Stock Valuation 7XE
Financials 7XE
Results | 2019 | Dynamics |